HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- New approvals for liver cancer mark ‘golden age’ of treatment Ryan Lawrence
-
- Is radioembolization appropriate for patients with limited extrahepatic spread?
- The new craze: Population health Nicholas J. Petrelli, MD, FACS
- ASH awards support resumption of hematologic research paused by pandemic
- Cleveland Clinic announces leadership appointments
- Daratumumab regimen safe, effective in newly diagnosed multiple myeloma Jennifer R. Southall
- Documentary aims to expose gender inequality, need for reform in surgical field Jennifer R. Southall
- Deferiprone approved for transfusional iron overload due to sickle cell disease
- Pembrolizumab-based regimen approved for first-line treatment advanced HER2-positive gastric cancer
-
- Loncastuximab tesirine-lpyl approved for relapsed or refractory DLBCL
- Wireless localization technology cleared for breast cancer surgery
- Huntsman Cancer Institute appoints senior director of clinical research innovation
- Wild-type KRAS linked to shorter OS with immunotherapy alone in NSCLC Jennifer R. Southall
- Lower Medicaid income limits linked to shorter survival among patients with cancer Ryan Lawrence
- Personalized vaccine shows potential benefit across cancer types Ryan Lawrence
- Poor lung function linked to fetal death among pregnant women with sickle cell disease Alexandra (Sasha) Todak
- Recommendations are ‘call to action’ for African American inclusion in myeloma trials Ryan Lawrence
-
- Regular PSA screening may improve prostate cancer outcomes among younger Black men Alexandra (Sasha) Todak
- Researchers identify rare pathogenic germline variants in children with sporadic neuroblastoma Alexandra (Sasha) Todak
- Society of Surgical Oncology announces president, executive council officers
- Tumor mutational burden predicts treatment response among women, not men, with melanoma Jennifer R. Southall
- Task force lowers age to start colorectal cancer screening to 45 years Kate Burba